Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase. 2006

Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
Laboratory for Medicinal Chemistry (FFW), Gent University Harelbekestraat 72, Gent, Belgium.

Herein we describe the synthesis and conformational analysis of a series of bicyclic thymidine derivatives and their evaluation as inhibitors of thymidine monophosphate kinase from Mycobacterium tuberculosis (TMPKmt), based on previously discovered bicyclic sugar nucleosides. With a K(i) value of 2.3 microm, 1-[3-aminomethyl-3,5-dideoxy-2-O,6-N-(thiocarbonyl)-beta-D-ribofuranosyl]thymine emerged as the most potent TMPK inhibitor of this series. Moreover, this promising compound displays inhibitory potency against Mycobacteria cultures with an IC(99) value of 100 microg mL(-1), thus promoting TMPKmt for the first time as a validated target for further inhibitory design. Attempts to rationalise the observed structure-activity relationship (SAR) involving molecular modelling and conformational analysis are described.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009703 Nucleoside-Phosphate Kinase An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4. Nucleoside Monophosphate Kinases,Kinase, Nucleoside-Phosphate,Kinases, Nucleoside Monophosphate,Monophosphate Kinases, Nucleoside,Nucleoside Phosphate Kinase
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine

Related Publications

Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
November 2015, Bioorganic & medicinal chemistry,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
October 2023, Applied biochemistry and biotechnology,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
January 2020, Bioorganic chemistry,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
December 2011, European journal of organic chemistry,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
September 2022, Bioorganic chemistry,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
March 2011, Bioorganic & medicinal chemistry letters,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
September 2001, Bioorganic & medicinal chemistry letters,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
July 2008, ChemMedChem,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
March 2007, Bioorganic & medicinal chemistry letters,
Ineke Van Daele, and Hélène Munier-Lehmann, and Pieter M S Hendrickx, and Gilles Marchal, and Pierre Chavarot, and Matheus Froeyen, and Li Qing, and José C Martins, and Serge Van Calenbergh
June 2018, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!